Yuewen Gong, BM, MSc, PhD

College of Pharmacy research theme

Biomedical

Keywords

• Biotechnology
• Cellular biology
• Cholestasis
• Liver fibrosis and cancer
• Molecule biology
• Natural products
• Short interfering RNA
• Vaccine

Research affiliations

Max Rady College of Medicine

Research groups

Liver disease research group

Research summary

The focus of Dr. Gong’s research program is on investigation of liver diseases such as fibrosis, hepatocellular carcinoma and cholangiocarcinoma as well as development of vaccine and short interfering RNA to inhibit the expression of several cytokines such as transforming growth factor beta and bone morphogenetic proteins. Other research interests include stem cell differentiation, isolation of different types of cells from the liver, recombinant DNA technology.

In collaboration with investigators in China, Dr. Gong is investigating mechanisms of fatty liver diseases and chronic kidney diseases and developing therapeutic products from Chinese herbal medicine.

The research in Dr. Gong’s laboratory has been supported by the Health Science Foundation, the Manitoba Medical Service Foundation, private pharmaceutical companies, the Canadian Institute of Health Research (CIHR) and the Natural Science and Engineering Research Council (NSERC). 

The research collaboration with the China-Japan Friendship Hospital in Beijing China has also resulted in research funding in China from National Natural Science Foundation of China and the Ministry of Science and Technology of Chinese Government to investigate traditional Chinese herbal medicines and diseases in the liver and kidney.